Rankings
▼
Calendar
PHAT FY 2025 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PHAT
Phathom Pharmaceuticals, Inc.
$891M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$175M
+216.9% YoY
Gross Profit
$153M
87.1% margin
Operating Income
-$160M
-91.4% margin
Net Income
-$221M
-126.3% margin
EPS (Diluted)
$-3.03
Cash Flow
Operating Cash Flow
-$167M
Free Cash Flow
-$167M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$259M
Total Liabilities
$697M
Stockholders' Equity
-$438M
Cash & Equivalents
$130M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$175M
$55M
+216.9%
Gross Profit
$153M
$47M
+222.6%
Operating Income
-$160M
-$277M
+42.3%
Net Income
-$221M
-$334M
+33.8%
← Q4 2024
All Quarters
Q1 2025 →